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Electroporation Based Therapies-Original Article
Moderate Heat Application Enhances
the Efficacy of Nanosecond Pulse
Stimulation for the Treatment
of Squamous Cell Carcinoma
Chelsea M. Edelblute, MS1, Siqi Guo, MD1, James Hornef, MS1,2,
Enbo Yang, PhD1, Chunqi Jiang, PhD1,2,
Karl Schoenbach, Dr. rer. nat.1,3, and Richard Heller, PhD1,3
Abstract
Nanosecond pulse stimulation as a tumor ablation therapy has been studied for the treatment of various carcinomas in animal
models and has shown a significant survival benefit. In the current study, we found that moderate heating at 43C for 2minutes
significantly enhanced in vitro nanosecond pulse stimulation-induced cell death of KLN205 murine squamous cell carcinoma cells by
2.43-fold at 600 V and by 2.32-fold at 900 V, as evidenced by propidium iodide uptake. Furthermore, the ablation zone in KLN205
cells placed in a 3-dimensional cell-culture model and pulsed at a voltage of 900 V at 43Cwas 3 times larger than in cells exposed to
nanosecond pulse stimulation at room temperature. Application of moderate heating alone did not cause cell death. A nanosecond
pulse stimulation electrode with integrated controllable laser heating was developed to treat murine ectopic squamous cell car-
cinoma.With this innovative system, we were able to quickly heat and maintain the temperature of the target tumor at 43C during
nanosecond pulse stimulation. Nanosecond pulse stimulation with moderate heating was shown to significantly extend overall
survival, delay tumor growth, and achieve a high rate of complete tumor regression. Moderate heating extended survival nearly
3-fold where median overall survival was 22 days for 9.8 kV without moderate heating and over 63 days for tumors pulsed with 600,
100 ns pulses at 5 Hz, at voltage of 9.8 kV with moderate heating. Median overall survival in the control groups was 24 and 31 days
for mice with untreated tumors and tumors receiving moderate heat alone, respectively. Nearly 69% (11 of 16) of tumor-bearing
mice treated with nanosecond pulse stimulation with moderate heating were tumor free at the completion of the study, whereas
complete tumor regression was not observed in the control groups and in 9.8 kV without moderate heating. These results suggest
moderate heating can reduce the necessary applied voltage for tumor ablation with nanosecond pulse stimulation.
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Introduction
Squamous cell carcinomas are one of the most common types of
ectodermal cancer. These cancers arise as a malignancy in
renewable squamous epithelial cells in the skin, esophagus, lung,
and cervix. Cutaneous squamous cell carcinoma is the second
most common form of nonmelanoma skin cancer, accounting for
an estimated 20% of all skin cancers, with its incidence
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increasing among the aging population.1 Moreover, squamous
cell carcinomas make up 10% to 15% of all lung cancers.2
Irreversible electroporation (IRE) has recently emerged as a
viable tool for cancer therapy, providing a minimally invasive
treatment platform that is both tolerable and effective.3-5 As a
nonthermal ablation technology, IRE has advantages over
alternative therapies such as radiofrequency heating,6-8
cryotherapy, and hyperthermia,9 which are associated with
high morbidity and mortality due to thermal damage to extra-
cellular tissues and contiguous vital structures.10-13 However,
local relapse due to incomplete ablation and clinical complica-
tions associated with IRE protocols and electrode needle place-
ment14 limits its potential as a therapy.15-17 This limitation was
congruent with increasing tumor size, where a larger tumor
becomes more difficult to treat without complications.3
Current studies have extended IRE pulse protocols to the
nanosecond range. Nanosecond pulse stimulation (NPS) has
been shown to effect the barrier function not only on the extra-
cellular cell membrane but also on the membrane of intracel-
lular organelles.18-20 These biological effects likely assist the
killing action of short duration pulses. In vivo, NPS has been
used for the treatment of murine melanoma,21 hepatocellular
carcinoma in a rat,22,23 and murine squamous cell carcinoma.24
Furthermore, in humans, NPS was effective for the treatment of
basal cell carcinoma lesions.25
The effect of temperature on cells and biological tissues has
been well studied, where an increase in temperature yields an
increase in cell permeability.26,27 This dilation can facilitate the
transfer of otherwise impermeant deliverables, for example, plas-
mid DNA28 or chemotherapeutics29 to cells or tissues. When the
application of heat and electric field is combined, these effects are
more pronounced and delivery of extracellularmolecules is more
efficient.27,28 Additionally, a recent study demonstrated cooling
cells on ice following nanosecond pulse exposure had a synergis-
tic cytotoxic effect compared to cells moved to 37C after NPS.30
Our hypothesis is that a moderate increase in the tempera-
ture of the target tumor can sensitize the target tumor for NPS.
We previously demonstrated the combination of moderate heat
and IRE pulse protocols in an ectopic murine pancreatic ade-
nocarcinoma model, where tumor impedance was reduced with
the application of heat, and tumor regression and survival were
improved.31 In the current study, we used 100 ns pulses in
combination with controlled moderate heat from an infrared
laser to ablate squamous cell carcinomas. To test this hypoth-
esis, a 3-dimensional (3-D) agarose gel cell-culture model was
studied for in vitro tumor ablation. Furthermore, the efficacy of
moderate heating in combination with nanosecond pulse stimu-
lation (MH-NPS) for tumor ablation was evaluated in an ecto-
pic murine squamous cell carcinoma model.
Materials and Methods
3-D Cell Model
KLN205-ATCC CRL1453 (ATCC, Manassas, Virginia) mouse
lung squamous cell carcinoma cells were maintained in culture
with a complete growth medium of Eagle minimal essential
medium with 4 mM L-glutamine, supplemented with 10%
heat-inactivated fetal bovine serum, and 5% penicillin/
streptomycin. Cells were kept in a 37C incubator supplied
with 5% CO2. Cells were tested for mycoplasma and con-
firmed negative.
A 3-D agarose cell-culture model was adopted for in vitro
tumor ablation.31,32 Solutions of 1% and 2.5% low-gelling tem-
perature agarose in complete media were prepared and kept at
37C. A base layer of 900 mL 2.5% agarose was evenly poured
on the bottom of a 3.5 cm plate avoiding bubbles. The plate was
then chilled at 4C until addition of the cell suspension. Briefly,
3  106 KLN205 cells were resuspended in 1 mL of 1% low-
gelling agarose gently and overlaid on the 2.5% layer. The plate
was immediately chilled at 4C for 4 minutes to set, after which
the 3-D cell models were incubated at 37C for 20 minutes
before applying the pulse protocol.
Nanosecond Pulse Stimulation in a 3-D Cell Model
Electric pulses were delivered to the 3-D model using a 2-
needle electrode comprised of tungsten wires, with an electrode
gap of 1 mm. Experimental groups included cells pulsed at
ambient temperature and cells preheated to 43C before pulse
application. A heat block was used to reach and maintain 43C.
Temperature was monitored by a thermocouple inserted into
the edge of the agarose for the duration of the protocol. Pulsing
parameters were randomly selected so as to not bias one group
from another. To indicate the location of pulsing, a permanent
ink mark was made on the underside of the 3.5 cm plate to
indicate the location of each individual site. Sites of pulse
delivery were spaced such that one region would not overlap
or interfere with another. In total, no more than 10 pulsing,
heated, or no treatment sites were included on a single plate.
Two hundred pulses of a 300 ns pulse duration, a pulse fre-
quency of 50 Hz, and applied electric fields of 150, 300, 600,
750, and 900 V were used as the pulsing parameters. A sham
control, where the electrode was inserted into the agarose with-
out delivering pulses, and a heat-only control were included.
Plates were returned to the incubator for 2 hours before asses-
sing cell death.
Quantification of Cell Death
Two hours after pulsing, cells were stained with propidium
iodide (4 mg/mL) to distinguish the live cells from the dead
cells; 1 Dulbecco phosphate buffered saline (DPBS) was
supplemented to each well for imaging. Immunofluorescence
micrographs were taken on an Olympus IX71 fluorescent
stereo microscope using an Olympus DP71 CCD camera
(Olympus, Center Valley, Pennsylvania). The permanent ink
mark was used as a guide under bright field to first locate
individual sites, then the fluorescence filter was applied for
visualizing cell death. All micrographs were taken at the same
exposure conditions. Quantification of fluorescence signal was
done using ImageJ software (Version 1.47). The integrated
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fluorescence density was determined by drawing a region of
interest around the area of fluorescence signal. The average
integrated fluorescence density of 3 to 5 samples is reported
(+ standard deviation).
Determination of Ablation Zone
Fluorescence micrographs of pulsed cells for quantifying cell
death were also used in determining the area of ablation using
ImageJ software. A scale was set for each image using the 1 mm
electrode gap as a guide. The center point of the 2 electrode
imprints, that is, the areas void of cells, served as end points
of the 1 mm scale. After setting the scale, a horizontal line was
drawn from the center of the ellipse to the edge of increasing
fluorescence intensity, encompassing the region with the highest
propidium iodide uptake. This measurement served as the semi-
major axis (mm). Similarly, a vertical line, perpendicular to the
length, was drawn from the center of the ellipse to the edge of
increasing fluorescence intensity, also encompassing the region
with the highest propidium iodide uptake. This measurement
served as the semi-minor axis (mm). The area of the ellipse-
shaped ablation zone (mm2) was calculated by multiplying the
semi-major and semi-minor axes by p wherein A ¼ pab. The
average of 3 to 5 samples is reported (+ standard deviation).
Two Dimensional Electric Field Simulation of MH-NPS
To quantify the electric field distribution, 2 dimensional
(2-D) numerical simulations were performed using the
commercially available finite element method solver COM-
SOL Multiphysics (Version 5). A 2-D electrostatic model was
created using experimental data from in vitro NPS with and
without heating. We utilized data from our strongest NPS para-
meter, 900 V, at room temperature and 43C for constructing
the simulation. Using the electrode specifications of 2 tungsten
wires measuring 0.25 mm in diameter and water as the sub-
strate medium, an electric field diagram was created in the
plane perpendicular to the needle electrodes. The electric field
was mapped in color (V/m) and contoured (V) per the 1 mm
electrode gap and applied electric field.
Murine Tumor Model
Female DBA/2 mice (6-8 weeks of age) were purchased from
Jackson Laboratories (Bar Harbor, Maine). Mice were injected
with 1  106 KLN205 cells in 50 mL (DPBS) subcutaneously
on a preshaven left flank. A total of 50 mice were used for this
experiment. The size of the primary tumor was assessed by
digital calipers twice a week along with body weight and clin-
ical observation of the animals. Tumor volume was determined
using the following formula: V¼ pab2/6, where a is the longest
diameter and b is the shortest diameter perpendicular to a. Mice
were euthanized at the end of the follow-up period or when
they met clinical criterion described at experimental end points,
such as morbidity, or with a threshold tumor volume at or
exceeding 1000 mm3. Mice that were tumor free at the
completion of the study were challenged on the opposite, right
flank, with 5  105 KLN205 cells in 50 mL DPBS. This tumor
volume was recorded. All experimental protocols were
approved by the Old Dominion University Institutional Animal
Care and Use Committee, and all experiments were performed
in accordance with relevant guidelines and regulations.
Laser Heating and Control System
To achieve controlled heating and maintain a constant surface
temperature of the treatment object at 43C, a programmable
and automatically adjustable heating system was designed. The
heating system consists of a 980 nm wavelength infrared laser
(Lasermate Group Inc, Walnut, California), whose optical
emission can be modulated in time, an optical fiber that deli-
vers the infrared laser light to the treatment surface, a thermo-
pile (ZTP-135SR, Amphenol Advanced Sensors, St. Mary’s,
Pennsylvania) that serves as a temperature sensor for the irra-
diated surface, and a programmable control circuit providing
laser modulation and the collected temperature information to a
LabVIEW (2014) interface. The temperature of the target tis-
sue was maintained by opening and closing the laser beam
shutter, automatically controlled with an Arduino propor-
tional–integral–derivative controller.
Electrode Design
A 4-needle 5 mm  7 mm rectangular array was utilized for
MH-NPS to squamous cell carcinoma tumors. The laser fiber
was secured in the center of the array, providing heat to the area
within the applied electric field. The probe was encased in a
Teflon cylinder. With this arrangement, a Gaussian distribution
of the infrared irradiation was measured in an independent cali-
bration study and the beam width was determined to be 2 mm
(based on 10%-90% value). This complements the electric field
strength distribution of the 4-needle array electrodes, which was
illustrated and detailed in our previous work.31 A thermopile was
included in the electrode configuration and positioned on the
side at such an angle to accurately record the surface temperature
at the site of the laser irradiation (Figure 1A). Individual sheaths
of ethylene tetrafluoroethylene tubing were used to cover the
shaft of each needle electrode, leaving just 3 mm of the electrode
unsheathed or exposed (Figure 1B). This accommodated a safer
placement of the electrode over the tumor, wherein the sheath
served as a barrier to prevent the needles from being inserted too
deeply into the animal, avoiding injury to the internal organs
from needle placement. The sheathing also provided insulation
between the needles and the thermopile, reducing local electrical
breakdown from high-voltage noise.
Moderate Heating Nanosecond Pulse Stimulation
of Tumors
Mice were anesthetized for MH-NPS. To anesthetize, animals
were placed in an induction chamber infused with a mixture of
3% to 5% isofluorane and 97% oxygen gas for several minutes.
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Once anesthetized, mice were fitted with a standard rodent
mask supplied with 2% to 3% isofluorane and 97% to 98%
oxygen to maintain a surgical plane of anesthesia. Excess fur
was removed from the area surrounding the tumor before pulse
application. Squamous cell carcinoma tumors were treated
when they reached an average size of *50 mm3, approxi-
mately 1 week after induction. A single ablative treatment was
applied. The electrode was positioned to cover the entire area
of tumor, with the needles inserted completely into the skin.
The pulse parameters for ablation were 600, 100 ns pulses, at a
frequency of 5 Hz. The experimental groups included 9.8 kV
without heat, 9.8 kV with heat, 15.4 kV without heat, 15.4 kV
with heat, and 21 kV without heat. Untreated tumors were
included as a control group. In the heated tumors, the laser
fiber was applied prior to delivering the pulses, and for the
duration of the pulse protocol once the target temperature of
43C was reached. A temperature of 43C was maintained for
the entirety of the pulse protocol. A heat-only control with no
applied pulses was also included, where the tumor was pre-
heated to 43C and maintained at that temperature for the
length of time required to complete the pulse protocol, that
is, 2 minutes. After completion of treatment, each mouse was
monitored continuously until recovered from anesthesia, as
indicated by their ability to maintain sternal recumbency and
to exhibit purposeful movement.
Statistical Analysis
Statistical significance between groups in the 3-D cell model
was determined using a 2-way analysis of variance (ANOVA)
with a Tukey-Kramer multiple comparisons posttest. Results are
expressed as the mean of 3 to 5 replicates per group (+ standard
deviation). Significant results were determined with respect to
cells exposed to pulses at room temperature unless otherwise
noted. A P value less than .05 was considered significant.
Statistical significance between the groups for the murine
tumor model was determined by 2-way ANOVA with a Tukey-
Kramer multiple comparisons test (GraphPad Prism Software,
La Jolla, California). Results are expressed as the mean of 5 to
8 individual replicates per group (+ standard deviation). Sig-
nificant results were determined with respect to untreated con-
trols unless otherwise noted. A P value less than .05 was
considered significant. A log-rank test was performed between
treatment groups for the Kaplan-Meir survival curve.
Results
Moderate Heating Nanosecond Pulse Stimulation
is Cytotoxic to KLN205 Cells in a 3-D Cell Model
In a 3-D agarose cell-culture model, nanosecond pulses applied
to KLN205 squamous cell carcinoma cells preheated to 43C
were more lethal than against cells pulsed at room temperature
(P < .001), as indicated by a higher propidium iodide uptake in
the heated condition (Figure 2D, F, H, J, and L). Significant
propidium iodide uptake was not observed in the sham control
nor when cells were exposed to heat alone without pulses (Figure
2A and B). In cells pulsed at room temperature (Figure 2C, E, G,
I, and K), distinct propidium iodide uptake was not observed at
an applied voltage of 150 V (Figure 2C) and was only observed
around the high-voltage electrodes, not in the center of the
applied field, in the 300 V condition (Figure 2E). Cell killing
between the electrodes was observed starting at a dose of 600 V
in cells pulsed at room temperature (Figure 2G). In contrast,
though not significant, we observed cell killing within the elec-
trode gap at the minimal dose of 150 V in cells preheated to 43C
(Figure 2D). This effect was linear with respect to increasing
applied voltage, wherein a higher applied voltage yielded
enhanced propidium iodide uptake and a higher fluorescence
signal (P < .001; Figure 2M). The integrated fluorescence den-
sity was similar for cells preheated to 43C and pulsed with 150
V to cells pulsed at room temperature with 750 V (Figure 2M).
Moderate Heating Nanosecond Pulse Stimulation
Widens the Ablation Zone in a 3-D Cell Model
Following nanosecond pulse application, KLN205 cells in a 3-
D model exhibited an ablation zone that widened as the applied
Figure 1. Electrode array for MH-NPS. Four-needle high-voltage
electrodes are arranged in a 5 mm 7 mm array with center port for an
infrared laser fiber. Thermopile for surface temperature monitoring is
angled toward target (A). Ethylene tetrafluoroethylene tubing sheaths
high-voltage needle electrodes leaving 3 mm exposed to insert into
target tumor (B). MH-NPS indicates nanosecond pulse stimulation
with moderate heating.
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voltage was increased (Figure 2N). In cells that were pulsed at
43C, this effect was more pronounced, with an elliptical-
shaped ablation zone of 3.93 + 0.50 mm2 achieved with the
application of 900 V. This area was significant with respect to
cells pulsed at room temperature with 900 V, where a maximal
ablation zone of only 1.33+ 0.01 mm2 was reached (P < .001;
Figure 2. Propidium iodide uptake after nanosecond pulse stimulation with and without the application of moderate heat. A 2-needle electrode
with a 1 mm gap was used to pulse KLN205 cells with 200, 300 ns pulses at 50 Hz with voltages of 150, 300, 600, 750, and 900 V at either room
temperature (RT; C, E, G, I, K) or 43C (D, F, H, J, L). A sham control (0 V) without pulses at RT (A) and 43C (B) was also recorded.
Micrographs are representative of 3 to 5 replicates per treatment group. Scale bar ¼ 1 mm. Quantification of cell death after nanosecond pulse
stimulation is represented as the integrated fluorescence density of each individual sample using ImageJ software to draw a region of interest
around the area of fluorescence signal. Results shown are the mean of 3 to 5 replicates per group (standard deviation). ***P < .001 (M). The area
of the ellipse-shaped ablation zone (mm2) was calculated by multiplying the semi-major and semi-minor axes indicative of propidium iodide
uptake by p wherein A ¼ pab. The calculated area is shown as mm2. Results shown are the mean of 3 to 5 replicates per group (+ standard
deviation). *P < .05, *P < .01, ***P < .001 (N).
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Figure 2N). Furthermore, at the minimal dose of 150 V, a
distinct region of killing was not observed, though an ablation
zone of 0.80+ 0.26 mm2 resulted from cells pulsed at 43C at
the same voltage.
Electric Field of NPS Is Enhanced With Application of MH
In a 3-D agarose cell-culture model, nanosecond pulses applied
to KLN205 squamous cell carcinoma cells preheated to 43C
were more lethal than against cells pulsed at room temperature
as evidenced by higher propidium iodide uptake. Overlaid elec-
tric field diagram for cells pulsed at 900 V at room temperature
where an electric field of 7 kV/cm was needed to achieve the
size of the ablation zone (Figure 3A). By comparison, an over-
laid electric field diagram for cells preheated to 43C and
pulsed at 900 V indicates that an electric field of approximately
1.5 kV/cm was needed to achieve the much larger size of the
ablation zone (Figure 3B).
Tumor Ablation With NPS Is Enhanced With MH
Tumor growth or regression was recorded following treatment.
Tumor growth was highest in the untreated tumors, in tumors
treated with heat alone, and in tumors receiving 600, 100 ns
pulses at 9.8 kV without heat (Figure 4A). No complete
responses were observed in the aforementioned groups.
Tumors treated with 21 kV or 15.4 kV with or without MH
showed a significant tumor volume reduction from day 18 to
day 63 compared to untreated controls (P < .05). Tumor regres-
sion was significant in tumors treated with 9.8 kV with MH
starting from day 25 after treatment (P < .05). The marked
reduction in tumor volume included a large percentage of com-
plete regressions, particularly at the later time points. The larg-
est difference between moderately heated and unheated pulsed
tumors were those treated with 9.8 kV (Figure 4B).
Overall Survival Is Improved for Mice Treated With
MH-NPS
Survival was significantly enhanced in tumors treated at 21 kV
(P < .001), 15.4 kV þ heat (P < .001), 15.4 kV (P < .001), and
9.8 kV þ heat (P < .01) compared to untreated tumors (Figure
4C). At day 63 after treatment, mice receiving tumor-targeted
pulses at 21 kV and 15.4 kV þ heat exhibited the highest
survival rates of 80% and 75%, respectively. Similarly, sur-
vival rates of 62.5% and 50% were observed in mice with
tumors treated at 15.4 kV and 9.8 kVþ heat in that order. Mice
receiving 9.8 kV without heat were all euthanized due to clin-
ical criteria, for example, excessive tumor burden or morbidity,
at or before day 25, and similarly for animals dosed with heat
alone by day 42. In the untreated controls, mortality was 100%
by day 31. We did not observe a protective effect in any treat-
ment group when the tumor-free mice were challenged with
KLN205 cells on the opposite flank (Figure 4D).
Discussion
The current study indicates that MH-NPS can be used to ablate
ectopic murine squamous cell carcinoma tumors. Thermal
damage occurs as a function of increasing temperature and time
of heating; therefore, our goal was to create a system for apply-
ing controlled MH in combination with NPS. Our electrode
delivery system for MH-NPS achieves that.
To avoid heat-induced cell death, 43C was chosen as the
target temperature, as temperatures above 43C have been
shown to induce cell death.33 The duration of MH at a target
temperature of 43C is approximately 2minutes. Heating
KLN205 carcinoma cells in a 3-D culture model did not cause
cell death, and MH alone had minimal effect on in vivo tumor
growth and no effect on survival. However, we observed a
synergistic cytotoxic effect between MH and NPS in both a
3-D cell-culture model and with in vivo tumor regression.
Additionally, MH-NPS significantly widened the ablation zone
in a 3-D cell model, particularly in the region between the
electrodes where the applied electric field is the weakest. The
MH-NPS also enhanced overall survival in vivo compared to
that of animals treated with NPS alone at the same voltage.
A possible explanation for the synergistic effect between
MH and NPS is the increase in tumor conductivity, indicated
by a large decrease in tumor impedance. Our group previously
reported this phenomenon in a pancreatic cancer model using
IRE protocols, wherein the actual dose of energy to the tumor
was higher in tumors treated with both MH and IRE compared
to those treated with IRE alone, resulting in enhanced tumor
ablation.31 Using MH-NPS to treat squamous cell carcinoma,
we see this same effect, where parallel treatments at the same
voltage, with one including MH, improve the rate of tumor
regression. Other groups have utilized laser heating for antitu-
mor effects34,35 but not in combination with NPS.
In summation, with the addition of moderate heat, the
applied voltage can be reduced to achieve the same treatment
efficacy. Our results suggest a reduction of at least 27% in the
Figure 3. Two-dimensional electrostatic model of NPS with and
without MH. Fluorescence micrograph indicating propidium iodide
uptake after NPS with 200, 300 ns pulses at 50 Hz with 900 V at RT
(A) and MH-NPS at 43C (B) and overlaid electric field contour.
Highest level of propidium iodide uptake was observed at an electric
field strength of 7 kV/cm (A) and 1.5 kV/cm (B) for cells pulsed at RT
and preheated to 43C, respectively. MH-NPS indicates nanosecond
pulse stimulation with moderate heating; RT, room temperature.
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applied voltage (21 to 15.4 kV þ heat) to achieve a similar
level in both tumor regression and overall survival. In addition,
at an even lower voltage, 9.8 kV, with MH-NPS, we observed a
significant survival enhancement compared to untreated mice
and those treated with NPS or MH alone, suggesting the vol-
tage could be dropped by as much as 53% to obtain a similar
level of tumor regression and to improve overall survival. This
is an important finding considering the invasive nature of
tumor resection and ablative surgeries and that high applied
voltages are often associated with major complications.3 There
is also an equipment limitation. Higher applied voltages require
a larger power supply, possibly multiple electrodes, and in
general greater engineering support to achieve the desired dose.
Therefore, using lower applied voltages is more feasible for
both the patient and the clinician.
We do not propose MH-NPS to be an alternative thermal
ablation platform. Current microwave and radiofrequency
ablative therapies are most efficient for thermal ablation, where
the goal is to raise the target tumor temperature to a lethal
temperature, thereby inducing necrosis or apoptosis.36 Instead,
Figure 4. Tumor regression after MH-NPS. KLN205 ectopic murine squamous cell carcinoma tumors were given a single MH, NPS, or
MH-NPS treatment on day 0 at an approximate size of 50 mm3. Tumor volume was recorded in surviving animals until day 63 (A). Groups
include an untreated no treatment control (no Tx), tumors treated with heat alone, tumors pulsed at a voltage of 9.8 kV or 15.4 kV with and
without the application of heat, and tumors pulsed at a voltage 21 kV. A total of 50 mice were used in this experiment. Results of 9.8 kV with and
without heat are displayed separately to observe difference between tumors heated and not heated at that voltage (B). Results shown are the mean
of 5 to 8 replicates per group (+ standard error of the mean) at day 0. Sample size is lower at later time points due to euthanasia by clinical
criteria. Kaplan-Meier survival curves are reported until the completion of the study at day 63 (C). A total of 50 mice were used for this
experiment. All groups included 8 mice per treatment with the exception of the no treatment control (no Tx) and 21 kV groups, which each
contained 5 animals. Mice tumor free at 63 days where challenged on the opposite flank with 5 105 KLN2015 cells. Challenge tumor volumes
were recorded. Results shown are the mean of 4 to 6 tumor-free replicates per group (+ standard error of the mean), as not all mice were tumor
free by day 63 (D). MH-NPS indicates nanosecond pulse stimulation with moderate heating.
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our platform provides fast, focused MH (43C) to the target
tissue only; a benefit of utilizing a laser heating source versus
microwaves37-39 or radiofrequency,6-8,36 whose temperatures
can exceed 100C and 150C, respectively, and can in some
cases stimulate heat-induced tumor spreading.40 By combining
low-voltage NPS with a moderate amount of heat, we can
mitigate theses deleterious effects providing high-power fast
heating with an infrared laser. In the current study, we have
demonstrated a synergy between heat-induced cell dilation and
application of NPS, thereby enhancing the cytotoxic effects of
NPS alone and avoid thermal damage or heat-induced cell
death. The greatest effort will be to accommodate the treatment
of larger tumors, specifically those with a diameter larger than
3 cm. This size limitation was indicated in clinical data from
IRE ablation therapies.3 Penetration depth and variation in
thermal properties of tissue are inherent physical challenges
for clinical applications involving large tumors. Preliminary
studies show that variation in heat absorption coefficients
among tissues of the same thickness is relatively small com-
pared to that in tissues of different thickness. Although tissue
deep below the surface may receive less heating compared to
the surface initially, heating the target for a period of time, for
example, 3 minutes, could reduce the absorption coefficient at
the surface and hence allow deeper penetration of the heating
and treatment. More studies are in progress to determine the
absorption coefficients and their dependence on tissue and tem-
perature. In these complex cases, multiple lasers may be
needed to achieve MH of larger targets. Data from our 3-D
in vitro cell-culture model, where an ablation zone nearly 4
times larger than the area of the applied electric field was
achieved, suggest we can treat larger tumors with modifica-
tions to electrode and laser configurations. Future work will
focus on the effort to treat larger, orthotopic tumors of various
cancer types with MH-NPS.
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